COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
While face masks are thought to play an important role in mitigating the epidemiological risks of COVID-19, new research aims to understand how well various types of cloth masks and even “nonmedical” surgical masks work.
First EUA for at-home and over-the-counter COVID-19 testing removes the need for clinical laboratories to perform COVID-19 diagnostic testing.
Week-by-week flu surveillance data show influenza testing in clinical laboratories compared to public health laboratories. While flu cases may be down, testing appears up.
The COVID-19 testing calculator tool developed by NIBIB is a mathematical model-based calculator that produces customized scenarios for COVID-19 surveillance testing.
While the availability of a nonprescription, at-home COVID-19 test collection kit will certainly increase the ease with which testing can be obtained, this new EUA seems to benefit LabCorp exclusively.
More on a recent study of 67 routine clinical laboratory tests that sought to identify COVID-19 biomarkers.
While face masks are thought to play an important role in mitigating the epidemiological risks of COVID-19, new research aims to understand how well various types of cloth masks and even “nonmedical” surgical masks work.
First EUA for at-home and over-the-counter COVID-19 testing removes the need for clinical laboratories to perform COVID-19 diagnostic testing.
Week-by-week flu surveillance data show influenza testing in clinical laboratories compared to public health laboratories. While flu cases may be down, testing appears up.
The COVID-19 testing calculator tool developed by NIBIB is a mathematical model-based calculator that produces customized scenarios for COVID-19 surveillance testing.
While the availability of a nonprescription, at-home COVID-19 test collection kit will certainly increase the ease with which testing can be obtained, this new EUA seems to benefit LabCorp exclusively.
More on a recent study of 67 routine clinical laboratory tests that sought to identify COVID-19 biomarkers.
